1. |
朱正纲. 应进一步提高胃癌综合治理的疗效 [J]. 中华胃肠外科杂志, 2007, 10(5): 403-406.
|
2. |
Shin HR, Jung KW, Won YJ, et al. National cancer incidence for the year 2002 in Korea [J]. Cancer Res Treat, 2007, 39(4):139-149.
|
3. |
詹文华. 规范胃恶性肿瘤的外科治疗 [J]. 中国普通外科杂志,2000, 9(4): 289-291.
|
4. |
Aurello P, D’Angelo F, Nigri G, et al. Comparison between site N-category and number N-category for nodal staging in carcinoma of the gastroesophageal junction:our experience and literature review [J]. Am Surg, 2006, 72(2):118-123.
|
5. |
Karpeh MS, Leon L, Klimstra D, et al. Lymph node staging in gastric cancer:is location more important than number? An analysis of 1 038 patients [J]. Ann Surg, 2000, 232(3):362-371.
|
6. |
Siewert JR, Böttcher K, Stein HJ, et al. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study [J]. Ann Surg, 1998, 228(4):449-461.
|
7. |
Sobin LH, Hermanek P, Hutter RV. TNM classification of malignant tumors. A comparison between the new (1987) and the old editions[ J]. Cancer, 1998, 61(11):2310-2314.
|
8. |
Oliver HB, Donald EH, Robert VP, et al. Manual for staging of cancer, American Joint Committee on cancer [M]. 4th ed. Philadelphia:JB Lippincott, 1992:53-56.
|
9. |
Fleming ID, Cooper JS, Henson DE, et al. Manual for staging of cancer, American Joint Committee on cancer [M]. 5th ed. New York: Springer, 1997:71-76.
|
10. |
Greene FL, Page DL, Fleming ID, et al. AJCC cancer staging manual, 6th ed [J]. Ann Oncol, 2003, 14(2):345-346.
|
11. |
Sobin LH, Wittekind CH. UICC TNM classification of malignant tumors, 5th ed [J]. Cancer, 1997, 80(9): 1803-1804.
|
12. |
Sobin LH, Wittekind CH. International Union Against Cancer (UICC):TNM classification of malignant tumors, 6th ed [M].New York:Wiley, 2002:52-56.
|
13. |
Sayegh ME, Sano T, Dexter S, et al. TNM and Japanese staging systems for gastric cancer:how do they coexist? [J]. Gastric Cancer, 2004, 7(3):140-148.
|
14. |
日本胃癌學會. 胃癌處理規約 [M]. 14 版. 東京:金原出版,2010: 438.
|
15. |
Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition [J]. Gastric Cancer,2011, 14(5):101-112.
|
16. |
Wu CW, Hsiung CA, Lo SS, et al. Nodal dissection for patients with gastric cancer:a randomised controlled trial [J]. Lancet Oncol, 2006, 7(4):309-315.
|
17. |
Sano T, Sasako M, Yamamoto S, et al. Gastric cancer surgery:morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy—Japan Clinical Oncology Group Study 9501 [J]. J Clin Oncol, 2004, 22(14): 2767-2773.
|
18. |
Wu CW, Chang IS, Lo SS, et al. Complications following D3 gastrectomy:post hoc analysis of a randomized trial [J]. World J Surg, 2006, 30(1): 12-16.
|
19. |
Wu CW, Chiou JM, Ko FS, et al. Quality of life after curative gastrectomy for gastric cancer in a randomised controlled trial [J]. Br J Cancer, 2008, 98(1): 54-59.
|
20. |
Songun I, Putter H, Kranenbarg EM, et al. Surgical treatment of gastric cancer:15-year follow-up results of the randomised nationwide DUTCH D1 and D2 trial [J]. Lancet Oncol, 2010, 11(5): 439-449.
|
21. |
Peng JJ, He YL, Zhan WH, et al. Vagina vasorum dissection during D2 lymphadenectomy for gastric carcinoma [J]. World J Gastroenterol, 2007, 13(12):1867-1869.
|
22. |
何裕隆. 胃癌淋巴转移 [M]. 北京:人民卫生出版社, 2011:17.
|
23. |
彭建军, 何裕隆, 詹文华, 等. 进展期胃癌对胃周围血管鞘的影响 [J]. 中国胃肠外科杂志, 2007, 10(1): 49-52.
|
24. |
韩方海, 詹文华, 何裕隆, 等. 影响胃癌患者术后生存因素的Cox 分析 [J]. 中国普外基础与临床杂志, 2006, 13(1): 29-35.
|
25. |
韩方海, 詹文华, 何裕隆, 等. 胃癌根治手术网膜囊及筋膜切除问题 [J]. 中国普外基础与临床杂志, 2007, 14(2): 230-234.
|